Tavernier G, Galitzky J, Valet P, Remaury A, Bouloumie A, Lafontan M, Langin D
Institut National de la Santé et de la Recherche Médicale Unité 317, Institut Louis Bugnard, Faculté de Médicine, Université Paul Sabatier, Toulouse, France.
Am J Physiol. 1995 Jun;268(6 Pt 1):E1135-42. doi: 10.1152/ajpendo.1995.268.6.E1135.
The mechanisms underlying catecholamine control of lipolysis were studied in rat white adipocytes from epididymal, retroperitoneal, and subcutaneous fat depots. Sensitivity of subcutaneous adipocytes to selective beta 3-adrenoceptor agonists was lower than that of internal adipocytes. beta 3-Adrenoceptor mRNA levels were lower in subcutaneous adipocytes. A decreased beta 1/beta 2-adrenoceptor-mediated lipolysis was also observed in these adipocytes, and the number of beta 1/beta 2-adrenoceptors was lower than in the internal adipocytes. The number of alpha 2-adrenoceptors was higher in subcutaneous adipocytes without a marked difference in alpha 2-adrenoceptor-mediated antilipolysis between the depots. Subcutaneous adipocytes were also characterized by a lower maximal lipolytic response to drugs acting at different levels of the lipolytic cascade, suggesting differences at the postreceptor level. Lower hormone-sensitive lipase activity and mRNA levels in subcutaneous adipocytes were in agreement with the lipolysis data. These results suggest that the pattern of expression of the genes of the lipolytic pathway varies with the anatomic location of the fat depot.
在来自附睾、腹膜后和皮下脂肪库的大鼠白色脂肪细胞中研究了儿茶酚胺控制脂肪分解的潜在机制。皮下脂肪细胞对选择性β3-肾上腺素能受体激动剂的敏感性低于内部脂肪细胞。皮下脂肪细胞中β3-肾上腺素能受体mRNA水平较低。在这些脂肪细胞中还观察到β1/β2-肾上腺素能受体介导的脂肪分解减少,并且β1/β2-肾上腺素能受体的数量低于内部脂肪细胞。皮下脂肪细胞中α2-肾上腺素能受体的数量较高,各脂肪库之间α2-肾上腺素能受体介导的抗脂解作用无明显差异。皮下脂肪细胞的另一个特征是对作用于脂肪分解级联不同水平的药物的最大脂肪分解反应较低,这表明在受体后水平存在差异。皮下脂肪细胞中较低的激素敏感性脂肪酶活性和mRNA水平与脂肪分解数据一致。这些结果表明,脂肪分解途径基因的表达模式随脂肪库的解剖位置而变化。